For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Blog
Trump’s State of the Union: A closer look at the claims
Last night, President Trump delivered a State of the Union address filled with optimism, applause lines, and bold claims about the country’s direction. There…
Search Posts
Op-Eds
Biotech Woes…and the Culprits
<?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />America learned long ago that what's good for General Motors isn't necessarily good for the country.
News Release
Two Groups Sue Transportation Department over Fuel Economy Standards
<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Click here for audio soundbites (mp3), soundbite 1; soundbite 2.
News Release
On 114th Anniversary of Turning Point in Chemistry, CEI Unveils Politically Correct Periodic Table
Contact: <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Jody Clarke, 202.331.2252 Sam Kazman, 202.331.2265 …
Op-Eds
Biotech and Baby Food
<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Warnings about one societal danger or another often portray children as the likeliest or…
Op-Eds
The EU’s Anti-Biotech Protectionist Weapon (Letter to the Editor)
America’s challenge to EU policies toward agricultural and food biotechnology is far more complex and subtle than is conveyed by U.S. Trade Representative Robert…
Op-Eds
OMB OTL? What good is a sleeping watchdog?
What would you do if federal lawmakers proposed increasing annual taxes by $8,000 per household? You, and many other taxpayers, would likely retaliate in…
